Equities Lead Investor Sentiment - Research Report on Questcor Pharmaceuticals, Inc. and Eastman Chemical Company

Marketwired

HONG KONG--(Marketwire -06/20/12)- Today, www.EquityLeader.com introduced research coverage of Questcor Pharmaceuticals, Inc. (QCOR) and Eastman Chemical Company (EMN). Full research reports are available to readers at: www.EquityLeader.com/index.php?sm1=QCOR&sm2=EMN.

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Equity Leader has decided to cover Questcor Pharmaceuticals, Inc. for its current position within the healthcare industry. Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company's primary product is H.P. Acthar Gel (repository corticotropin injection) (Acthar), an injectable drug that is approved by the United States Food and Drug Administration, for the treatment of 19 indications. As of December 31, 2011, H.P. A copy of this report detailing Questcor Pharmaceuticals, Inc. (QCOR) is available at: www.EquityLeader.com/index.php?sm1=QCOR.

Equity Leader is also taking note of Eastman Chemical Company for its changing role within the basic materials industry. Eastman Chemical Company (Eastman) is a global chemical company, which manufactures and sells a portfolio of chemicals, plastics, and fibers. Eastman has 19 manufacturing sites in 10 countries and interests in joint ventures that supply chemicals, plastics, and fibers products to customers throughout the world. To download free research on Eastman Chemical Company (EMN) investors may visit: www.EquityLeader.com/index.php?sm2=EMN.

About Equity Leader
Whether you are a first time investor or seasoned market professional, Equity Leader provides the resources necessary to simplify your research process. Our focus has always been to empower investors with the information they need to make their own investment decisions.

Contact:
View Comments (0)